{"id":516726,"date":"2021-07-22T16:11:16","date_gmt":"2021-07-22T20:11:16","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\/"},"modified":"2021-07-22T16:11:16","modified_gmt":"2021-07-22T20:11:16","slug":"opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\/","title":{"rendered":"Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SANTA MONICA, Calif., July  22, 2021  (GLOBE NEWSWIRE) &#8212; Opiant Pharmaceuticals, Inc.\u00a0(\u201cOpiant\u201d) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today\u00a0announced it will report its financial results for the second quarter ended June 30, 2021, after the financial markets close on\u00a0Thursday, August 5, 2021.<\/p>\n<p>The Company\u2019s management team is scheduled to host a conference call and webcast at\u00a04:30 p.m. ET\u00a0on\u00a0Thursday, August 5, 2021. To access the call, please dial 888-394-8218 in the\u00a0U.S.\u00a0or 323-794-2588 outside the\u00a0U.S.\u00a0and provide the conference ID number: 5960603. To access the live webcast, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CsPkoKWMH9PXN-GnfcLn--_sKB14WrCuZKxLsZb73y3UXDOo_MI5LgBm2B2KyfFeMzkcFg4ryDc-wD4995fKeox5dKwEqlVtpFP5e3fpWmf95Mt6NVtkwLuCuFf8FVKSnbL-RwDFJZEp5F3p3UDtJ5XqbCKZ5VkXAq8u7_57hnUq4ynamm5CM8YOT8Ux9HAMNPbCpSRABkj6pAKkvTtSn7ukJRbEwc_twTl3oRrd-8vbdg6sQuvnVy27SN9S_oupQ3lU_j4gh4atqgYGolE2M3HU4TT-H_h1QmFuKc2B1NtLjdSg12txukQHyq3hIVNtuGOgMiQ7tXeO6A4U-481_eI65vQTHBMsXrVaFYuFlUdLr9d7OUZYW-SzNu-bnkmpuLUogb7MN79nkGInTMT-7imhXigassIWSz_H9okS6e3WegYMYWeBSh1kWNV6oVlKuuUTRdyK1zHQr7iNncRAE4zqO87H0mLiH6lXpirw7L_WiPlXY8iNHspgT3-l9hkhxPAuz4FNW2q2qU4Hb3RajFCxGpRDVgSVgSGZHzH7hp-L_6awEO2tiRN43PWAhhx1Ey6X75OYHoNrH_Rv13yAoHQt6PWZOqfnPH2WjsiDANcIBMlbzAELTlG8ciTFKlDm2nN1ZWMnxjDB7Ls5H9cD8Ef_wYpOCio1dtBGbw1w55QTQDlW2rdfVngimBLPPFw4qqFzVKWEe-SgykuxCQ0Hg4w1bQdMnb3gGc-NlwZ0cIxY7AX9jVmad1NbF5jLYL5j1cVWEGB1O2WxBMmHuxHS478DQIlb7BOrHV3Ifr9h_9qDmF2af6yyq2fL7Hmox-X0\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/public.viavid.com\/index.php?id=145669<\/a>. Following the live webcast, an archived version of the call will be available on the website.<\/p>\n<p>\n        <strong><br \/>\n          <em>Thursday\u00a0August 5\u00a0@\u00a04:30 pm ET<\/em><br \/>\n        <\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:40%;width:40%;min-width:40%;text-align: left;vertical-align: middle;vertical-align: top\">Domestic:<\/td>\n<td style=\"max-width:60%;width:60%;min-width:60%;text-align: left;vertical-align: middle;vertical-align: top\">888-394-8218<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">International:<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">323-794-2588<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">Conference ID:<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">5960603<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">Webcast:<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\n            <a href=\"https:\/\/shared.outlook.inky.com\/link?domain=public.viavid.com&amp;t=eyJ0eXAiOiJKV1QiLCJhbGciOiJFUzI1NiJ9.eJxtkN1Og0AQhd9lr0kpbW0sibEarGnTLqliEEJCFnYrA8NPWCBA47u7eGM03s58Z-accyWNYDlwYhKEi5AxMN6BLGtJNAJFI-qCITEvDKXQiFBYVJYZFB_bDlgHfBaXuSIn_a9BWysVSZqmMgM90Ks2QohnP0igQ8FFP6uS6h74nbG6Wa83Sme_EbNoETXSJLVgTYiiE-rUXLmZnkTPmPvvNGXuLuM5jtHyMB6Xjwl3-4d_dzntotcNeosX9FKe-ZZn-M5p7ju7xLbOI3WfFn56HqjjI7UO6Qlue5ruDTruB9vxhmMar6Y4UtShyBlgyDivhZTKS8Va3P5p7Tv-5xcemHXJ.MEUCIH7WsFMNWeR_rB9CNhTDVF7cN9cMj75wnZmcz6x80FSaAiEA9pICmllIVnvannuZ4pDnIl4K6uhY49mHxj216WrG5kQ\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/public.viavid.com\/index.php?id=145669<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        <strong>About\u00a0Opiant\u00a0Pharmaceuticals, Inc.<\/strong><br \/>\n        <br \/>Opiant Pharmaceuticals, Inc., the company that developed NARCAN<sup>\u00ae<\/sup> Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YxHyMY34eHthJgBWwRIK6nu9g0fjt0ts4hx9h2VxmCtBdvOA_Ltt9w2iRmpHQOWE8Na1_RBhfsmsW-4GuUF40tkKp1A8A--zc3U1s8mNTWUESmlKE9EBa6vdu5AuS7zLNtRnchMoyxVY-xLHaXf5vwyoMDVy4mL8c2DE-sA9iAp1A1IlhDomSG9qVMUxGYMpJ4E9ISYeggHkrRTIHuA6BdhG-6IVILKLjAfcWpAvUG4=\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.opiant.com<\/u><\/a>.<\/p>\n<p>\n        <strong>For Media and Investor Inquiries:<\/strong><br \/>\n        <br \/>Ben Atkins, Opiant<br \/>(310) 598-5410<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TeO-kWAefUa8c2OYEshCcVv7ozLFjLPbT2Uh3hYby9VDdbGv7NDq6zQdN68vF8v-lOz_Xk0_hVCmhqkRWn4HxhfiY-Rc2NbebKNz5RFdEck=\" rel=\"nofollow noopener\" target=\"_blank\"><u>batkins@opiant.com<\/u><\/a><\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NTMwNiM0MzEwNjUzIzIwMjAwNTY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/369d79b4-799a-4b5f-b1c1-aaafebb338ca\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SANTA MONICA, Calif., July 22, 2021 (GLOBE NEWSWIRE) &#8212; Opiant Pharmaceuticals, Inc.\u00a0(\u201cOpiant\u201d) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today\u00a0announced it will report its financial results for the second quarter ended June 30, 2021, after the financial markets close on\u00a0Thursday, August 5, 2021. The Company\u2019s management team is scheduled to host a conference call and webcast at\u00a04:30 p.m. ET\u00a0on\u00a0Thursday, August 5, 2021. To access the call, please dial 888-394-8218 in the\u00a0U.S.\u00a0or 323-794-2588 outside the\u00a0U.S.\u00a0and provide the conference ID number: 5960603. To access the live webcast, please visit http:\/\/public.viavid.com\/index.php?id=145669. Following the live webcast, an archived version of the call will be available on the website. Thursday\u00a0August 5\u00a0@\u00a04:30 pm ET Domestic: 888-394-8218 International: 323-794-2588 Conference ID: &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-516726","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SANTA MONICA, Calif., July 22, 2021 (GLOBE NEWSWIRE) &#8212; Opiant Pharmaceuticals, Inc.\u00a0(\u201cOpiant\u201d) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today\u00a0announced it will report its financial results for the second quarter ended June 30, 2021, after the financial markets close on\u00a0Thursday, August 5, 2021. The Company\u2019s management team is scheduled to host a conference call and webcast at\u00a04:30 p.m. ET\u00a0on\u00a0Thursday, August 5, 2021. To access the call, please dial 888-394-8218 in the\u00a0U.S.\u00a0or 323-794-2588 outside the\u00a0U.S.\u00a0and provide the conference ID number: 5960603. To access the live webcast, please visit http:\/\/public.viavid.com\/index.php?id=145669. Following the live webcast, an archived version of the call will be available on the website. Thursday\u00a0August 5\u00a0@\u00a04:30 pm ET Domestic: 888-394-8218 International: 323-794-2588 Conference ID: &hellip; Continue reading &quot;Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-22T20:11:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NTMwNiM0MzEwNjUzIzIwMjAwNTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021\",\"datePublished\":\"2021-07-22T20:11:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\\\/\"},\"wordCount\":205,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NTMwNiM0MzEwNjUzIzIwMjAwNTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\\\/\",\"name\":\"Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NTMwNiM0MzEwNjUzIzIwMjAwNTY=\",\"datePublished\":\"2021-07-22T20:11:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NTMwNiM0MzEwNjUzIzIwMjAwNTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NTMwNiM0MzEwNjUzIzIwMjAwNTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\/","og_locale":"en_US","og_type":"article","og_title":"Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021 - Market Newsdesk","og_description":"SANTA MONICA, Calif., July 22, 2021 (GLOBE NEWSWIRE) &#8212; Opiant Pharmaceuticals, Inc.\u00a0(\u201cOpiant\u201d) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today\u00a0announced it will report its financial results for the second quarter ended June 30, 2021, after the financial markets close on\u00a0Thursday, August 5, 2021. The Company\u2019s management team is scheduled to host a conference call and webcast at\u00a04:30 p.m. ET\u00a0on\u00a0Thursday, August 5, 2021. To access the call, please dial 888-394-8218 in the\u00a0U.S.\u00a0or 323-794-2588 outside the\u00a0U.S.\u00a0and provide the conference ID number: 5960603. To access the live webcast, please visit http:\/\/public.viavid.com\/index.php?id=145669. Following the live webcast, an archived version of the call will be available on the website. Thursday\u00a0August 5\u00a0@\u00a04:30 pm ET Domestic: 888-394-8218 International: 323-794-2588 Conference ID: &hellip; Continue reading \"Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-22T20:11:16+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NTMwNiM0MzEwNjUzIzIwMjAwNTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021","datePublished":"2021-07-22T20:11:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\/"},"wordCount":205,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NTMwNiM0MzEwNjUzIzIwMjAwNTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\/","name":"Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NTMwNiM0MzEwNjUzIzIwMjAwNTY=","datePublished":"2021-07-22T20:11:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NTMwNiM0MzEwNjUzIzIwMjAwNTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NTMwNiM0MzEwNjUzIzIwMjAwNTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-5-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/516726","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=516726"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/516726\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=516726"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=516726"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=516726"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}